Yunnan Botanee Bio-Technology Group Co.LTD

XSEC:300957 Stock Report

Market Cap: CN¥20.0b

Yunnan Botanee Bio-Technology GroupLTD Past Earnings Performance

Past criteria checks 1/6

Yunnan Botanee Bio-Technology GroupLTD has been growing earnings at an average annual rate of 9.4%, while the Personal Products industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 20.9% per year. Yunnan Botanee Bio-Technology GroupLTD's return on equity is 9.9%, and it has net margins of 9.7%.

Key information

9.4%

Earnings growth rate

6.5%

EPS growth rate

Personal Products Industry Growth7.8%
Revenue growth rate20.9%
Return on equity9.9%
Net Margin9.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Yunnan Botanee Bio-Technology GroupLTD makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:300957 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,1085923,535317
30 Jun 245,9597913,235304
31 Mar 245,7567753,145298
31 Dec 235,5227573,036299
30 Sep 235,5501,1132,712310
30 Jun 235,3321,1062,590282
31 Mar 235,0691,0642,424258
01 Jan 235,0141,0512,390255
30 Sep 224,8051,0252,353171
30 Jun 224,6609932,270152
31 Mar 224,3239302,107121
01 Jan 224,0228631,932113
30 Sep 213,3326831,62285
30 Jun 213,1076481,45082
31 Mar 212,8255681,37872
31 Dec 202,6365441,28163
31 Dec 191,94441298451
31 Dec 181,24026163243
31 Dec 1779815441528

Quality Earnings: 300957 has a large one-off gain of CN¥186.1M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 300957's current net profit margins (9.7%) are lower than last year (20.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300957's earnings have grown by 9.4% per year over the past 5 years.

Accelerating Growth: 300957's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300957 had negative earnings growth (-46.8%) over the past year, making it difficult to compare to the Personal Products industry average (-6%).


Return on Equity

High ROE: 300957's Return on Equity (9.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies